Rezultati pretraživanja
  1. prije 7 sati

    "It is a tragedy that lung cancer rates are over 80% higher in the most deprived areas of the UK – and that detection rates vary by more than 20% from region to region." Pauline Armory and Maxine Arnott from the ECLS trial in letters to The today

    1 proslijeđeni tweet 2 korisnika označavaju da im se sviđa
  2. prije 21 sat

    Learn about our innovations to fight including - Easy access to clinical trials - Thoracic - "Equality of great !"

    6 proslijeđenih tweetova 14 korisnika označava da im se sviđa
  3. 4. velj

    Today is . This year's theme, "I Am and I Will," is all about YOU and your commitment to act to reduce the number of premature deaths from cancer. That’s why I talk to everyone I meet about

    2 proslijeđena tweeta 10 korisnika označava da im se sviđa
  4. 4. velj

    Today is . Together, we can raise awareness about prevention & detection through exams. Cancer caught early is the most treatable

    1 proslijeđeni tweet
  5. 3. velj

    Progress on policy seems to be taking place internationally. This news from Scotland. Hopefully release of will allow final push for implementation.

    1 proslijeđeni tweet 3 korisnika označavaju da im se sviđa
  6. 31. sij

    There are about 47,000 cases of in the UK each year. Nearly three-quarters of them are caused by .

    5 proslijeđenih tweetova 4 korisnika označavaju da im se sviđa
  7. 31. sij

    Screening for saves lives. is seeking feedback from the public in designing an Australian-first lung cancer screening program for people at high risk of lung cancer. Have your say here:

  8. 31. sij
    Odgovor korisnicima

    Because we spend our days telling patients presenting with stage IV lung cancer they will die... please review the extensive published literature on anxiety and stress associated with . It is minimal.

    2 korisnika označavaju da im se sviđa
  9. 30. sij

    NELSON trial results in NEJM, 29 Jan 2020. Conclusion: Volume CT screening for lung cancer in high risk populations significantly rly reduces lung cancer mortality in men (24%) & women (33-59%).

    1 proslijeđeni tweet 3 korisnika označavaju da im se sviđa
  10. 30. sij

    Great to see the discussions following publication y'day. I remember sitting in the plenary at listening to Harry DeKoning first present this data in Toronto. Check out the PC that followed (start at 16.10)

    9 proslijeđenih tweetova 24 korisnika označavaju da im se sviđa
  11. 30. sij

    Thread by : trial overview & comments:

    2 proslijeđena tweeta 7 korisnika označava da im se sviđa
  12. 30. sij

    New research finds guidelines are insufficient for

    1 proslijeđeni tweet
  13. 30. sij
    Odgovor korisniku/ci

    Saluti, there is your unroll: Thread by : trial overview & comments: Click here for the full publication:… . Share this if you think it's interesting. 🤖

  14. 30. sij

    Focus moving forward is to implement internationally and improve screening rates where programs have already been initiated (USA).

    1 reply
    Prikaži ovu nit
    Prikaži ovu nit
  15. 30. sij

    trial overview & comments: Click here for the full publication: and editorial:

    1 reply 4 proslijeđena tweeta 8 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
  16. 30. sij

    NELSON Trial: LDCT vs Nothing > 15,000 pts < overall tobacco exposure than NLST 23% survival adv in men 34% survival adv in women < 2% false + rate 10% over dx rate Need to only screen 132 patients to save one life (those are great #’s) 2/2

    MEDICAL COMMUNITY: Can we stop fooling ourselves by saying there is not enough data? Start saving lives and refer your high risk patients to screening! “Reduced Mortality with Volume CT Screening in a Randomized Trial” | NEJM 1/2
    11 proslijeđenih tweetova 29 korisnika označava da im se sviđa
  17. 30. sij

    NELSON trial results are published with further evidence of the benefit of

    High-risk patients were screened for lung cancer in a population-based RCT using volume-based nodule management for further testing. At 10 yrs follow up, lung cancer mortality was 2.5 per 1000 person years in the screened arm and 3.3 in the control arm.
    1 korisnik označava da mu se sviđa
  18. 30. sij

    is coming

    1 proslijeđeni tweet 4 korisnika označavaju da im se sviđa
  19. 29. sij

    editorial "There can no longer be any doubt as to the efficacy of periodic low-dose CT screening in reducing mortality from lung cancer"

    1 reply 25 proslijeđenih tweetova 56 korisnika označava da im se sviđa
  20. 29. sij

    Australians from every sector with an interest in – have your say and contribute to the Lung Cancer Screening enquiry

    4 proslijeđena tweeta 3 korisnika označavaju da im se sviđa

Nema rezultata.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.